Back to search

Boston University

Preventing CVD: treatment of elevated lipoprotein(a) with respect to LPA gene isoform type

Abstract

dc:description.abstract

Lipoprotein(a) [Lp(a)] is a unique low density lipoprotein consisting of an apolipoprotein(a) and apolipoprotein B subunit that is an established genetic risk factor for atherosclerotic cardiovascular disease (ASCVD). Current therapeutic options for inherited elevated circulating Lp(a) are generally limited to off-target effects of other cardiovascular therapies, making treatment for this condition difficult. This work evaluates a variety of established cardiovascular treatments and their impact on Lp(a) plasma concentration while taking into consideration potential impacts of Lp(a) isoform types on treatment response. It also assesses the value of Lp(a) lowering therapies based on their relative cardioprotective benefit, lowering or preventing occurrences of major adverse cardiovascular events (MACE) and ASCVD.

Degree

thesis:*
Name thesis:degree_name
Master of Science
Level thesis:degree_level
masters
Discipline thesis:degree_discipline
Medical Sciences
Grantor
Boston University
Year dc:date.issued
2024

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Brooks, Alexis
Advisors dc:contributor.advisor
  • Moreira-Bouchard, Jesse
  • Gerstenfeld, Louis
ORCID dc:identifier.orcid

Subjects

dc:subject × 8

Rights

Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/2144/51376

Chain of custody

source
Harvested from
Boston University
Base URL
open.bu.edu/oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Brooks, Alexis. Preventing CVD: treatment of elevated lipoprotein(a) with respect to LPA gene isoform type. masters thesis, Boston University, 2024. https://hdl.handle.net/2144/51376